| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/29/2006 | WO2006068618A1 New compounds |
| 06/29/2006 | WO2006068213A1 Glycine derivative and use thereof |
| 06/29/2006 | WO2006068166A1 Dry granulated substance and process for producing the same |
| 06/29/2006 | WO2006068058A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067401A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | WO2006067385A1 Chemical compounds |
| 06/29/2006 | WO2006067312A2 Painkilling association comprising a dihydroimidazopyrazine derivative |
| 06/29/2006 | WO2006067311A2 Cdc25 phosphatase inhibitors |
| 06/29/2006 | WO2006067310A2 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
| 06/29/2006 | WO2006067114A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/29/2006 | WO2006066987A1 Anti-radical agents |
| 06/29/2006 | WO2006066968A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | WO2006066950A2 Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066894A1 Compounds for treating metabolic syndrome |
| 06/29/2006 | WO2006066637A1 Use of cyclodextrin complexes containing lipoic acid |
| 06/29/2006 | WO2006057886A3 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/29/2006 | WO2006057885A3 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/29/2006 | WO2006030322A3 Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions |
| 06/29/2006 | WO2006018314A3 Immune stimulatory infant nutrition |
| 06/29/2006 | WO2006016262A8 Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor |
| 06/29/2006 | WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases |
| 06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
| 06/29/2006 | US20060142391 Ppargamma-activating pharmaceutical composition |
| 06/29/2006 | US20060142385 Inhibitors of matrix metalloproteinase |
| 06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 06/29/2006 | US20060142357 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060142212 Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142201 amino acid sequence containing Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; prophylaxis; neuropathic pain, inflammation, incontinence, cardiovascular conditions |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060141044 Pharmaceutical compositions based on diclofenac derivate |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140950 Using interleukin-23 modulators to treat and prevent nervous system, gastrointestinal and autoimmune disorders |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140928 Use of heparinases to decrease inflammatory response |
| 06/29/2006 | US20060140905 Chemokine beta-7 variants |
| 06/29/2006 | CA2592442A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | CA2592170A1 Glycine derivative and use thereof |
| 06/29/2006 | CA2591946A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | CA2591757A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | CA2591217A1 Painkilling association comprising a dihydroimidazopyrazine derivative |
| 06/29/2006 | CA2591215A1 Cdc25 phosphatase inhibitors |
| 06/29/2006 | CA2591212A1 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
| 06/29/2006 | CA2590155A1 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| 06/29/2006 | CA2589748A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | CA2589367A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/29/2006 | CA2586973A1 Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674087A1 Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
| 06/28/2006 | EP1673371A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/28/2006 | EP1673344A1 1-(quinoline amino) and 1-(isoquinoline amino)-substituted pentan-2-ols, method for their production and their use as anti-inflammatories |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673086A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 06/28/2006 | EP1601677B1 Spiro-substituted pyrrolopyrimidines |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1392330B1 Use of lps for treating intestinal inflammation processes |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1140212B1 The use of radium-223 to target calcified tissues for pain palliation and therapy of bone cancer |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP0951281B1 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 06/28/2006 | EP0876143B1 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals |
| 06/28/2006 | CN1795206A Galectin 9-inducing factors |
| 06/28/2006 | CN1795185A Process for making substituted pyrazoles |
| 06/28/2006 | CN1795163A Carboxylic compound and medicine comprising the same |
| 06/28/2006 | CN1795027A Composition comprising lactobacilli or bifidobacteria and use thereof |
| 06/28/2006 | CN1795011A A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 06/28/2006 | CN1795008A Histamine binding compounds for treatment method for disease conditions mediated by neutrophils. |
| 06/28/2006 | CN1795003A Anti-inflammatory composition based on strontium compounds |
| 06/28/2006 | CN1792370A External use prepns. for wind-dispelling, removing-obstruction in channels to relieve pain |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261412C Indole derivatives as COXII inhibitors |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/28/2006 | CN1261151C Medicine for treating acute cholecystitis and chronic cholecystitis and its preparing method |
| 06/28/2006 | CN1261149C Medicine for treating rheumatoid arthritis, femur necrosis and ankylosing spondylitis |
| 06/28/2006 | CN1261139C Medicine for treating bone tuberculosis, osteomyelitis, synovitis and angiitis |
| 06/28/2006 | CN1261136C Plaster of external use for lumbar and leg pain |
| 06/28/2006 | CN1261135C Medicine for curing rheumatism and traumatic injury |
| 06/28/2006 | CN1261133C Combination of medicine for curing rheumatism involiving bone and preparation method |
| 06/28/2006 | CN1261129C External used Chinese medicine plaster for removing obstruction in channel powder |
| 06/28/2006 | CN1261110C Medicinal composition for treating common and infectious cold |
| 06/28/2006 | CN1261104C Glossy-ganoderma-spore polysaccharide for injection and its preparation process |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067657 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain |